569653-53-8

Piperazine, 1-[tetrahydro-4-(2-methylpropyl)-2H-thiopyran-4-yl]-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-(1,1-dimethylethyl)-4-ethyl-2-[[4-[2-(4-morpholinyl)ethoxy]phenyl]methyl]-

3-Piperidinamine,2-(3,5-dibromophenyl)-N-[[2-methoxy-5-(trifluoromethoxy)phenyl]methyl]-, (2R,3R)-rel-

4H-[1,2,5]Oxadiazino[5,4-a]indol-4-one, 1-(3-methoxyphenyl)-

1(2H)-Pyrazinecarboxylic acid,4-[(4-fluorophenyl)methyl]-3,4-dihydro-2-(2-methylpropyl)-3-oxo-,phenylmethyl ester, (2S)-

3-Pentanol, 1,1,1-trifluoro-

4H-[1,3,4]Thiadiazolo[2,3-c][1,2,4]triazin-4-one,7-[5-(2,4-dichlorophenyl)-2-furanyl]-3-(phenylmethyl)-

Glycine, N-[4-[(4,6-dichloro-2-benzothiazolyl)azo]-2-methylphenyl]-,2-[(2-ethylhexyl)oxy]ethyl ester

3-Oxetanemethanol, 3-phenyl-, 4-methylbenzenesulfonate

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-(1,1-dimethylethyl)-4-ethyl-2-[(4-methoxyphenyl)methyl]-6-methyl-

Glycine, N-[4-[[(2-hydroxyphenyl)methylene]amino]benzoyl]-, pentylester

3-Oxazolidinecarboxylic acid,4-butyl-2-(1,1-dimethylethyl)-5-oxo-4-(2-propenyl)-, 2-propenyl ester,(2S,4R)-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,4,7-diethyl-2-(3-pyridinylmethyl)-

4H-1,3,5-Thiadiazin-4-one,5-(2-chlorophenyl)-3-[(4-chlorophenyl)methyl]-2-[[(4-chlorophenyl)methyl]imino]tetrahydro-

3-Piperidinamine,N-[(tetrahydro-3-furanyl)methyl]-N-[[2-(trifluoromethyl)phenyl]methyl]-,(3S)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

Glycine, N-[4-[[(2-hydroxyphenyl)methylene]amino]benzoyl]-, propylester

4H-1,3,5-Oxadiazine,2-(difluoromethyl)-4,4-bis(trifluoromethyl)-6-[3-(trifluoromethyl)phenyl]-

3-Oxoninol, 9-ethyl-2,3,4,9-tetrahydro-2-(2Z)-2-penten-4-ynyl-,(2S,3R,5Z,7Z,9S)-

3-Oxazolidinecarboxylic acid,5-[(4-methoxyphenyl)methylene]-4-oxo-2-thioxo-

3-Penten-2-one,3-[3,5-bis(1,1-dimethylethyl)-2-hydroxyphenyl]-4-hydroxy-, (E)-

4H-[1,2,4]Triazolo[5,1-b]purine-2-carboxylic acid,7-cyclopentyl-4-ethyl-5,6-dihydro-5-oxo-6-(phenylmethyl)-

3-Piperidinecarboxamide,N-[trans-4-[(methylsulfonyl)amino]cyclohexyl]-1-(phenylsulfonyl)-, (3S)-

3-Oxetanemethanol, a-methyl-a-(4-methyl-3-pentenyl)-2-phenyl-,(2R,3R)-rel-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-2-(ethoxymethyl)-4-ethyl-

3-Pentanone, 1-(2-bromo-3,5-dimethoxyphenyl)-

2,4-Hexadienenitrile, 6-chloro-, (2E,4E)-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-4-ethyl-2-(1-hydroxyethyl)-

1-Undecen-5-ol, 4-methyl-4-[(phenylmethoxy)methyl]-, (4S,5R)-

3-Penten-2-one, 4-hydroxy-, (3E)-

4H-[1,2,4]Triazolo[5,1-b]purin-5(6H)-one,7-cyclopentyl-4-ethyl-2-[[4-(phenylmethoxy)phenyl]methyl]-

N-[[(4-methoxyphenyl)methoxy]carbonyl]-3-[(phenylmethyl)sulfinyl]-L-Alanine

3-Pentanol, 3-(propoxymethyl)-, erbium(3+) salt

4H-1,3,5-Dioxazine, 2,6-diphenyl-4,4-bis(trifluoromethyl)-

3-Pentanone, 1,5-bis(diethylamino)-, oxime

3-Oxazolidinecarboxylic acid,4-[3-[(4-nitrophenyl)amino]-3-oxopropyl]-5-oxo-, phenylmethyl ester,(4S)-

3-Pentanone, 1,1,1,2,4,4,5,5-octafluoro-2-(trifluoromethoxy)-

3-Phenanthrenemethanol, 4-bromo-1,2-dihydro-a-2-propenyl-

569653-53-8 msds

CAS No 569653-53-8 supplier

CASNo 569653-53-8 distributor

CAS # 569653-53-8 manufacturer

CAS Number 569653-53-8 safety

CAS RN 569653-53-8 wholesale

2026-10-13 Find Piperazine, 1-[tetrahydro-4-(2-methylpropyl)-2H-thiopyran-4-yl]-,CAS No.569653-53-8,Formula:C13H26N2S in ChemGloble